NAMS icon

NewAmsterdam Pharma
NAMS

Overview Fund Activity

32 hedge funds and large institutions have $692M invested in NewAmsterdam Pharma in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.47%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
4
Increased
9
Reduced
5
Closed
7
Calls
$13.4M
Puts
–
Net Calls
+$13.4M
Net Calls Change
+$10.7M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$15.5M
2
Millennium Management
2
Millennium Management
New York
$14.8M
3
OM
3
Opaleye Management
Massachusetts
$2.96M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$14.5M
5
Morgan Stanley
5
Morgan Stanley
New York
$638K

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$87.8M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$0
3
EP
3
Eversept Partners
New York
$4.18M
4
Ensign Peak Advisors
4
Ensign Peak Advisors
Utah
$2.14M
5
UOC
5
UBS O'Connor
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FLSM
1
Frazier Life Sciences Management
California
$136M – – –
FIS
2
FCPM III Services
Netherlands
$132M +$132M +11,831,461 New
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$117M – – –
Viking Global Investors
4
Viking Global Investors
Connecticut
$89.6M – – –
RCM
5
RA Capital Management
Massachusetts
$87.8M -$12.7M -1,136,000 -13%
MVM
6
Medicxi Ventures Management
Jersey
$32.1M – – –
BI
7
BVF Inc
California
$17M – – –
Goldman Sachs
8
Goldman Sachs
New York
$15.5M +$15.5M +1,384,321 New
GC
9
GMT Capital
Georgia
$15.5M – – –
Millennium Management
10
Millennium Management
New York
$14.8M +$3.14M +281,319 +27%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$14.5M +$1.12M +100,000 +8%
EP
12
Eversept Partners
New York
$4.18M -$3.2M -286,214 -43%
PHP
13
Parkman Healthcare Partners
Connecticut
$3.36M +$578K +51,726 +21%
Axa
14
Axa
France
$3.09M -$74.7K -6,687 -2%
OM
15
Opaleye Management
Massachusetts
$2.96M +$2.96M +265,388 New
Ensign Peak Advisors
16
Ensign Peak Advisors
Utah
$2.14M -$2.75M -245,777 -56%
AAA
17
Affinity Asset Advisors
New York
$1.4M – – –
SSA
18
Schonfeld Strategic Advisors
New York
$747K +$24.6K +2,200 +3%
Morgan Stanley
19
Morgan Stanley
New York
$638K +$619K +55,374 +3,253%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$529K +$61.6K +5,516 +13%
Marshall Wace
21
Marshall Wace
United Kingdom
$379K +$266K +23,777 +234%
BlackRock
22
BlackRock
New York
$256K – – –
Citadel Advisors
23
Citadel Advisors
Florida
$235K -$116K -10,351 -33%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$121K +$110K +9,875 +988%
VVP
25
Venture Visionary Partners
Ohio
$112K – – –
1
2